← Open Payments lookup

ADAM FRIEDMAN: Open Payments

NPI 1588800916 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639,415 in 435 payments from 31 companies in 2025. Trend: 2023 $269,711 · 2024 $382,323 · 2025 $639,415

Speaker / faculty: $305,931Consulting: $271,481Travel & lodging: $42,794Honoraria: $9,300Food & beverage: $8,889Grant: $1,000
CompanyPaymentsAmount
GENZYME CORPORATION40$130,225
Regeneron Healthcare Solutions, Inc.76$115,415
Lilly USA, LLC39$71,845
PFIZER INC.33$69,661
Galderma Laboratories, L.P.27$58,459
UCB, Inc.46$43,285
Novartis Pharmaceuticals Corporation25$24,438
Janssen Biotech, Inc.20$22,171
Arcutis Biotherapeutics, Inc.14$19,932
Incyte Corporation30$17,285

Products named: DUPIXENT, EBGLYSS, CIBINQO, Bimzelx, TREMFYA, Zoryve, SPEVIGO, OPZELURA.

Industry payments across DC — which companies pay providers there.